To the Editor, A multicenter, open-label, early access treatment protocol for ibrutinib in patients with relapsed or refractory mantle cell lymphoma

Peter Martin, Andre Goy, Radhakrishnan Ramchandren, Lucille Ferrante, Anil Londhe, Tracy McGowan, Nancy L. Bartlett

Research output: Contribution to journalLetterpeer-review

Fingerprint

Dive into the research topics of 'To the Editor, A multicenter, open-label, early access treatment protocol for ibrutinib in patients with relapsed or refractory mantle cell lymphoma'. Together they form a unique fingerprint.